Population-based survival statistics are fundamental to assess the efficacy of services offered to improve cancer patients' prognosis. This study aims to update cancer survival estimates for the Italian population, as well as provide new measures, such as the crude probability of death, which takes into account the possibility of dying from causes other than cancer, and the change in life expectancy after a cancer diagnosis, to properly address various questions.

OBJECTIVES: Population-based survival statistics are fundamental to assess the efficacy of services offered to improve cancer patients' prognosis. This study aims to update cancer survival estimates for the Italian population, as well as provide new measures, such as the crude probability of death, which takes into account the possibility of dying from causes other than cancer, and the change in life expectancy after a cancer diagnosis, to properly address various questions.RESULTS: The study includes 1,932,450 cancer cases detected by the Network of Italian Cancer Registries (AIRTUM) from 1994 to 2011 and provides estimates for 38 cancer sites and for allsites cancer. For most common cancers diagnosed from 2005 to 2009, age-standardized 5-year net survival was: colon-rectum - males 65%, females 65%; lung - males 15%, females 19%; breast 87%; prostate 91%. For cancer sites such as stomach, colon, rectum, lung, skin melanoma, breast, cervix, prostate, and kidney, 5-year net survival is consistent between Central and Northern Italy, while it is a few percentage points lower in Southern Italy. Funnel plots expose these differences more in detail by showing the survival estimates in 13 Italian regions. For all sites but skin, 5- and 10-year net survival increased by about 10 percentage points in men and 7 points in women from 1994 to 2011.DISCUSSION: Specific articles deal with results on solid and haematological malignancies, international comparisons and analysis of time trends of incidence, mortality, and survival in combination for key cancer sites, aiming to interpret overall progress in the control of cancer in Italy.

Survival of cancer patients in Italy [La sopravvivenza dei pazienti oncologici in Italia [La sopravvivenza dei pazienti oncologici in Italia] / Coviello, V; Buzzoni, C; Fusco, M; Barchielli, A; Cuccaro, F; De Angelis, R; Giacomin, A; Luminari, S; Randi, G; Mangone, L; AIRTUM Working, Group. - In: EPIDEMIOLOGIA E PREVENZIONE. - ISSN 1120-9763. - 41:2(2017), pp. 1-244. [10.19191/EP17.2S1.P001.017]

Survival of cancer patients in Italy [La sopravvivenza dei pazienti oncologici in Italia [La sopravvivenza dei pazienti oncologici in Italia]

Coviello V;Barchielli A;Luminari S;
2017

Abstract

Population-based survival statistics are fundamental to assess the efficacy of services offered to improve cancer patients' prognosis. This study aims to update cancer survival estimates for the Italian population, as well as provide new measures, such as the crude probability of death, which takes into account the possibility of dying from causes other than cancer, and the change in life expectancy after a cancer diagnosis, to properly address various questions.
41
2
1
244
Survival of cancer patients in Italy [La sopravvivenza dei pazienti oncologici in Italia [La sopravvivenza dei pazienti oncologici in Italia] / Coviello, V; Buzzoni, C; Fusco, M; Barchielli, A; Cuccaro, F; De Angelis, R; Giacomin, A; Luminari, S; Randi, G; Mangone, L; AIRTUM Working, Group. - In: EPIDEMIOLOGIA E PREVENZIONE. - ISSN 1120-9763. - 41:2(2017), pp. 1-244. [10.19191/EP17.2S1.P001.017]
Coviello, V; Buzzoni, C; Fusco, M; Barchielli, A; Cuccaro, F; De Angelis, R; Giacomin, A; Luminari, S; Randi, G; Mangone, L; AIRTUM Working, Group
File in questo prodotto:
File Dimensione Formato  
EP AIRTUM_2017.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 12.46 MB
Formato Adobe PDF
12.46 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1167742
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 0
social impact